← Browse by Condition
Medical Condition
solid tumours
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1
NCT07403370
Recruiting
Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis
Enrollment
2,000 pts
Location
China
Sponsor
Shandong Cancer Hospital and I...
NCT04529122
Recruiting
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
Enrollment
15,000 pts
Location
Argentina, Austria, ...
Sponsor
Hoffmann-La Roche
NCT06789172 Phase 1
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Enrollment
166 pts
Location
United States, Austr...
Sponsor
Epkin